Jockeying for position

Our latest post discusses recent updates on biomarker research across several cancer types.

These include several types of lung cancer, as well as prostate cancer, colorectal cancer, and bladder cancer.

Not all the trials mentioned returned a positive result, although some were much more encouraging. Either way, there is much to learn from the analyses and offer some pointers for the future.

Also included are a dozen or so pharma or biotech companies whose work might be impacted by the findings described within. Yours could be one of them…

To continue reading our latest highlights on oncology new product development including commentary and analysis, BSB subscribers can log-in or you can click to access the content.

This content is restricted to subscribers

Posted by